US2035401A
(en)
|
1933-10-21 |
1936-03-24 |
Dow Chemical Co |
Transportation of automobiles
|
US4658019A
(en)
|
1979-04-26 |
1987-04-14 |
Ortho Pharmaceutical Corporation |
Complement-fixing monoclonal antibody to human T cells
|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
US4714681A
(en)
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
EP0092918B1
(en)
|
1982-04-22 |
1988-10-19 |
Imperial Chemical Industries Plc |
Continuous release formulations
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
US5128326A
(en)
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
JP2532858B2
(ja)
|
1985-04-01 |
1996-09-11 |
セルテツク リミテツド |
形質転換したミエロ―マ細胞系
|
US5851526A
(en)
|
1985-04-19 |
1998-12-22 |
Ludwig Institute For Cancer Research |
Methods of treating colon cancer utilizing tumor-specific antibodies
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US5017691A
(en)
|
1986-07-03 |
1991-05-21 |
Schering Corporation |
Mammalian interleukin-4
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
DE3631229A1
(de)
|
1986-09-13 |
1988-03-24 |
Basf Ag |
Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
US4880078A
(en)
|
1987-06-29 |
1989-11-14 |
Honda Giken Kogyo Kabushiki Kaisha |
Exhaust muffler
|
US5306620A
(en)
*
|
1987-07-08 |
1994-04-26 |
The Scripps Research Institute |
Antibodies that bind to a ligand-induced binding site on integrin and induce integrin activation
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
US5336603A
(en)
|
1987-10-02 |
1994-08-09 |
Genentech, Inc. |
CD4 adheson variants
|
US5521153A
(en)
|
1987-10-02 |
1996-05-28 |
Ciba-Geigy Corporation |
Synergistic antifungal protein and compositions containing same
|
US6511665B1
(en)
*
|
1987-11-25 |
2003-01-28 |
Immunex Corporation |
Antibodies to interleukin-1 receptors
|
US4925648A
(en)
|
1988-07-29 |
1990-05-15 |
Immunomedics, Inc. |
Detection and treatment of infectious and inflammatory lesions
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
EP1892296A1
(en)
|
1988-09-02 |
2008-02-27 |
Dyax Corporation |
Generation and selection of recombinant varied binding proteins
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
CA2000048A1
(en)
|
1988-10-03 |
1990-04-03 |
Edward F. Plow |
Peptides and antibodies that inhibit integrin-ligand bindin g
|
US5149780A
(en)
|
1988-10-03 |
1992-09-22 |
The Scripps Research Institute |
Peptides and antibodies that inhibit integrin-ligand binding
|
US5360716A
(en)
|
1988-10-24 |
1994-11-01 |
Otsuka Pharmaceutical Co., Ltd. |
Human tumor necrosis factor αspecific monoclonal antibody and method for detecting human tumor necrosis factor α
|
KR900005995A
(ko)
|
1988-10-31 |
1990-05-07 |
우메모또 요시마사 |
변형 인터류킨-2 및 그의 제조방법
|
US5223395A
(en)
|
1988-12-01 |
1993-06-29 |
Centocor, Inc. |
Immunometric assays for tumor necrosis factor-alpha and methods for preventing the loss of biological activity of tumor necrosis factor-alpha in biological samples
|
US5734033A
(en)
|
1988-12-22 |
1998-03-31 |
The Trustees Of The University Of Pennsylvania |
Antisense oligonucleotides inhibiting human bcl-2 gene expression
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5147638A
(en)
|
1988-12-30 |
1992-09-15 |
Oklahoma Medical Research Foundation |
Inhibition of tumor growth by blockade of the protein C system
|
EP0394827A1
(en)
|
1989-04-26 |
1990-10-31 |
F. Hoffmann-La Roche Ag |
Chimaeric CD4-immunoglobulin polypeptides
|
US5766883A
(en)
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
US5498694A
(en)
*
|
1989-05-25 |
1996-03-12 |
La Jolla Cancer Research Foundation |
Peptides of the cytoplasmic domain of integrin
|
EP0739904A1
(en)
|
1989-06-29 |
1996-10-30 |
Medarex, Inc. |
Bispecific reagents for aids therapy
|
US5112946A
(en)
|
1989-07-06 |
1992-05-12 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
US5644034A
(en)
|
1989-08-07 |
1997-07-01 |
Peptide Technology Ltd. |
Tumour necrosis factor binding ligands
|
US5959087A
(en)
|
1989-08-07 |
1999-09-28 |
Peptide Technology, Ltd. |
Tumour necrosis factor binding ligands
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
EP1132471A3
(de)
|
1989-09-12 |
2001-11-28 |
F. Hoffmann-La Roche Ag |
TNF-bindende Proteine
|
WO1991005548A1
(en)
|
1989-10-10 |
1991-05-02 |
Pitman-Moore, Inc. |
Sustained release composition for macromolecular proteins
|
WO1991006570A1
(en)
|
1989-10-25 |
1991-05-16 |
The University Of Melbourne |
HYBRID Fc RECEPTOR MOLECULES
|
CA2071867A1
(en)
|
1989-11-06 |
1991-05-07 |
Edith Mathiowitz |
Method for producing protein microspheres
|
US5196511A
(en)
*
|
1989-12-01 |
1993-03-23 |
The Scripps Research Institute |
Peptides and antibodies that inhibit integrin-ligand binding
|
US5262520A
(en)
*
|
1989-12-01 |
1993-11-16 |
The Scripps Research Institute |
Peptides and antibodies that inhibit integrin-ligand binding
|
US5859205A
(en)
*
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
AU7247191A
(en)
|
1990-01-11 |
1991-08-05 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
US5136021A
(en)
|
1990-02-27 |
1992-08-04 |
Health Research, Inc. |
TNF-inhibitory protein and a method of production
|
DE4006269A1
(de)
|
1990-02-28 |
1991-08-29 |
Max Planck Gesellschaft |
Antikoerper gegen den tumor-nekrosefaktor-rezeptor
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
US5349053A
(en)
|
1990-06-01 |
1994-09-20 |
Protein Design Labs, Inc. |
Chimeric ligand/immunoglobulin molecules and their uses
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
KR100272077B1
(ko)
|
1990-08-29 |
2000-11-15 |
젠팜인터내셔날,인코포레이티드 |
이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
JPH07500961A
(ja)
|
1990-10-01 |
1995-02-02 |
ユニバーシティ オブ コネチカット |
細胞による選択的内在化を目的としたウイルス及び細胞の標的設定
|
JP3583420B2
(ja)
|
1990-10-05 |
2004-11-04 |
メダレツクス・インコーポレーテツド |
二特異的試薬を用いた標的免疫化
|
DE69128253T2
(de)
|
1990-10-29 |
1998-06-18 |
Chiron Corp |
Bispezifische antikörper, verfahren zu ihrer herstellung und deren verwendungen
|
US5830678A
(en)
*
|
1990-10-30 |
1998-11-03 |
Fred Hutchinson Cancer Research Center |
Method for identifying a target peptide that modulates the binding of epinectin ligand to integrin receptors
|
CA2405246A1
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with alterred binding properties
|
DE69123241T2
(de)
|
1990-12-14 |
1997-04-17 |
Cell Genesys Inc |
Chimärische ketten zur transduktion von rezeptorverbundenen signalwegen
|
US5994510A
(en)
|
1990-12-21 |
1999-11-30 |
Celltech Therapeutics Limited |
Recombinant antibodies specific for TNFα
|
GB9028123D0
(en)
|
1990-12-28 |
1991-02-13 |
Erba Carlo Spa |
Monoclonal antibodies against human tumor necrosis factor alpha
|
WO1992012176A1
(en)
|
1991-01-14 |
1992-07-23 |
New York University |
Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
|
ATE153768T1
(de)
|
1991-01-15 |
1997-06-15 |
Bayer Ag |
Ergänzung von oberflächenrezeptoren
|
US5656272A
(en)
|
1991-03-18 |
1997-08-12 |
New York University Medical Center |
Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
|
US5919452A
(en)
|
1991-03-18 |
1999-07-06 |
New York University |
Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
|
US5698195A
(en)
|
1991-03-18 |
1997-12-16 |
New York University Medical Center |
Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies
|
DE69233750D1
(de)
|
1991-04-10 |
2009-01-02 |
Scripps Research Inst |
Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
|
JP3431140B2
(ja)
|
1991-04-26 |
2003-07-28 |
サーフィス・アクティブ・リミテッド |
抗体およびその使用方法
|
CA2109528A1
(en)
|
1991-05-01 |
1992-11-02 |
Gregory A. Prince |
A method for treating infectious respiratory diseases
|
US5310874A
(en)
|
1991-05-03 |
1994-05-10 |
The Scripps Research Institute |
Integrin α subunit cytoplasmic domain polypeptides and antibodies
|
WO1992020316A2
(en)
|
1991-05-14 |
1992-11-26 |
University Of Connecticut |
Targeted delivery of genes encoding immunogenic proteins
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
AU2160992A
(en)
|
1991-06-05 |
1993-01-12 |
Board Of Regents Acting For And On Behalf Of The University Of Michigan, The |
Targeted delivery of genes encoding secretory proteins
|
JPH07503124A
(ja)
|
1991-06-14 |
1995-04-06 |
ゾーマ・コーポレーション |
微生物によって生産される抗体断片とそれらの複合体
|
CA2103059C
(en)
|
1991-06-14 |
2005-03-22 |
Paul J. Carter |
Method for making humanized antibodies
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
US5334380A
(en)
|
1991-09-27 |
1994-08-02 |
Board Of Regents, The University Of Texas System |
Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension
|
EP0607332B1
(en)
|
1991-10-07 |
1997-12-17 |
Biogen, Inc. |
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
|
US6162432A
(en)
|
1991-10-07 |
2000-12-19 |
Biogen, Inc. |
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
|
DE4135070C1
(xx)
|
1991-10-24 |
1993-05-19 |
Institut Fuer Rundfunktechnik Gmbh, 8000 Muenchen, De |
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
JP4157160B2
(ja)
|
1991-12-13 |
2008-09-24 |
ゾーマ テクノロジー リミテッド |
改変抗体可変領域の調製のための方法
|
US5824307A
(en)
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
AU3434393A
(en)
|
1992-01-17 |
1993-08-03 |
Regents Of The University Of Michigan, The |
Targeted virus
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
FR2686901A1
(fr)
|
1992-01-31 |
1993-08-06 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides antithrombotiques, leur preparation et compositions pharmaceutiques les contenant.
|
US6271242B1
(en)
|
1992-02-10 |
2001-08-07 |
Bristol-Myers Squibb Co. |
Method for treating cancer using a tyrosine protein kinase inhibitor
|
CA2089229C
(en)
|
1992-02-14 |
2010-04-13 |
Alejandro A. Aruffo |
Cd40cr receptor and ligands therefor
|
GB9203459D0
(en)
|
1992-02-19 |
1992-04-08 |
Scotgen Ltd |
Antibodies with germ-line variable regions
|
WO1993017715A1
(en)
|
1992-03-05 |
1993-09-16 |
Board Of Regents, The University Of Texas System |
Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
NL9200481A
(nl)
|
1992-03-13 |
1993-10-01 |
Univ Groningen |
Farmaceutisch preparaat met plaatsgerichte afgifte.
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
JPH07505773A
(ja)
|
1992-04-03 |
1995-06-29 |
ヤング アレキサンダー ティー |
標的化されたウイルスベクターを用いた遺伝子治療
|
EP0633945B1
(en)
|
1992-04-03 |
1998-12-30 |
Genentech, Inc. |
ANTIBODIES TO ALPHAvBETA3 INTEGRIN
|
US5478725A
(en)
*
|
1992-06-12 |
1995-12-26 |
University Of Pennsylvania |
αv β3 integrin as a predictor of endometriosis
|
US6005079A
(en)
|
1992-08-21 |
1999-12-21 |
Vrije Universiteit Brussels |
Immunoglobulins devoid of light chains
|
WO1994004678A1
(en)
|
1992-08-21 |
1994-03-03 |
Casterman Cecile |
Immunoglobulins devoid of light chains
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
US5741488A
(en)
|
1992-10-08 |
1998-04-21 |
The Kennedy Institute For Rheumatology |
Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies
|
AU689758B2
(en)
|
1992-10-09 |
1998-04-09 |
Advanced Tissue Sciences, Inc. |
Liver reserve cells
|
US5705481A
(en)
*
|
1992-11-06 |
1998-01-06 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
Cyclopeptides
|
CA2592997A1
(en)
|
1992-12-03 |
1994-06-09 |
Genzyme Corporation |
Pseudo-adenovirus vectors
|
US5441050A
(en)
|
1992-12-18 |
1995-08-15 |
Neoprobe Corporation |
Radiation responsive surgical instrument
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
DE4310643A1
(de)
*
|
1993-04-01 |
1994-10-06 |
Merck Patent Gmbh |
Cyclische Adhäsionsinhibitoren
|
ES2162863T3
(es)
|
1993-04-29 |
2002-01-16 |
Unilever Nv |
Produccion de anticuerpos o fragmentos (funcionalizados) de los mismos derivados de inmunoglobulinas de cadena pesada de camelidae.
|
US5728868A
(en)
|
1993-07-15 |
1998-03-17 |
Cancer Research Campaign Technology Limited |
Prodrugs of protein tyrosine kinase inhibitors
|
EP0733070A1
(en)
|
1993-12-08 |
1996-09-25 |
Genzyme Corporation |
Process for generating specific antibodies
|
US5925376C1
(en)
|
1994-01-10 |
2001-03-20 |
Madalene C Y Heng |
Method for treating psoriasis using selected phosphorylase kinase inhibitor and additional compounds
|
US5521169A
(en)
|
1994-01-14 |
1996-05-28 |
Bristol-Myers Squibb Company |
Ascosteroside and analogs thereof useful in antifungal compositions for methods of treating infections and inhibition of fungal growth
|
US5618709A
(en)
|
1994-01-14 |
1997-04-08 |
University Of Pennsylvania |
Antisense oligonucleotides specific for STK-1 and method for inhibiting expression of the STK-1 protein
|
ATE243745T1
(de)
|
1994-01-31 |
2003-07-15 |
Univ Boston |
Bibliotheken aus polyklonalen antikörpern
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US5834252A
(en)
|
1995-04-18 |
1998-11-10 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
IT1273790B
(it)
|
1994-02-18 |
1997-07-10 |
Guidotti & C Spa Labor |
Derivati eterociclici diazotati aventi attivita' aii antagonista
|
US5523209A
(en)
|
1994-03-14 |
1996-06-04 |
The Scripps Research Institute |
Methods for identifying inhibitors of integrin activation
|
US5753230A
(en)
*
|
1994-03-18 |
1998-05-19 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of angiogenesis
|
US5770565A
(en)
|
1994-04-13 |
1998-06-23 |
La Jolla Cancer Research Center |
Peptides for reducing or inhibiting bone resorption
|
DE4415310A1
(de)
|
1994-04-30 |
1995-11-02 |
Merck Patent Gmbh |
Cyclopeptide
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
US5985660A
(en)
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
WO1996000081A1
(en)
|
1994-06-24 |
1996-01-04 |
Immunex Corporation |
Controlled release polypeptide compositions and methods of treating inflammatory bowel disease
|
CN1117155C
(zh)
|
1994-07-29 |
2003-08-06 |
史密丝克莱恩比彻姆有限公司 |
新型化合物
|
US5587459A
(en)
|
1994-08-19 |
1996-12-24 |
Regents Of The University Of Minnesota |
Immunoconjugates comprising tyrosine kinase inhibitors
|
US5911995A
(en)
|
1994-08-19 |
1999-06-15 |
Regents Of The University Of Minnesota |
EGF-genistein conjugates for the treatment of cancer
|
SI0719859T1
(en)
*
|
1994-12-20 |
2003-12-31 |
Merck Patent Gmbh |
Anti-alpha V-integrin monoclonal antibody
|
ATE252894T1
(de)
|
1995-01-05 |
2003-11-15 |
Univ Michigan |
Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
|
US6030613A
(en)
|
1995-01-17 |
2000-02-29 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
DE69627820T2
(de)
|
1995-01-17 |
2004-04-08 |
The Brigham And Women's Hospital Inc., Boston |
Rezeptorspezifischer transepithelialer transport von immunogenen
|
GB9501567D0
(en)
|
1995-01-26 |
1995-03-15 |
Pharmacia Spa |
Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
|
US5998596A
(en)
|
1995-04-04 |
1999-12-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Inhibition of protein kinase activity by aptameric action of oligonucleotides
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
KR20050085971A
(ko)
|
1995-04-27 |
2005-08-29 |
아브게닉스, 인크. |
면역화된 제노마우스 유래의 인간 항체
|
AU2466895A
(en)
|
1995-04-28 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
DE69636339T2
(de)
|
1995-06-01 |
2007-07-19 |
Kishimoto, Tadamitsu, Tondabayashi |
Wachstumsinhibitor gegen leukämische zellen, der antisense-oligonukleotidderivate gegen das wilms-tumorgen enthält
|
US5767071A
(en)
|
1995-06-07 |
1998-06-16 |
Ixsys Incorporated |
Sevenmer cyclic peptide inhibitors of diseases involving αv β3
|
US5780426A
(en)
|
1995-06-07 |
1998-07-14 |
Ixsys, Incorporated |
Fivemer cyclic peptide inhibitors of diseases involving αv β3
|
EP0842948B1
(en)
*
|
1995-06-30 |
2009-04-22 |
Mochida Pharmaceutical Co., Ltd. |
ANTIFas LIGAND ANTIBODIES AND ASSAY METHOD BY USING THE SAME
|
GB9515975D0
(en)
|
1995-08-04 |
1995-10-04 |
Zeneca Ltd |
Chemical compounds
|
US5908839A
(en)
*
|
1995-08-24 |
1999-06-01 |
Magainin Pharmaceuticals, Inc. |
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
|
US5817750A
(en)
|
1995-08-28 |
1998-10-06 |
La Jolla Cancer Research Foundation |
Structural mimics of RGD-binding sites
|
EP0850051A2
(en)
|
1995-08-31 |
1998-07-01 |
Alkermes Controlled Therapeutics, Inc. |
Composition for sustained release of an agent
|
US5863904A
(en)
|
1995-09-26 |
1999-01-26 |
The University Of Michigan |
Methods for treating cancers and restenosis with P21
|
GB9601081D0
(en)
|
1995-10-06 |
1996-03-20 |
Cambridge Antibody Tech |
Specific binding members for human transforming growth factor beta;materials and methods
|
US6127366A
(en)
|
1995-11-22 |
2000-10-03 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
ES2175137T3
(es)
|
1995-12-08 |
2002-11-16 |
Janssen Pharmaceutica Nv |
Derivados de (imidazol-5-il)metil-2-quinolinona como inhibidores de laproteina farnesil-transferasa.
|
US5958769A
(en)
|
1996-01-18 |
1999-09-28 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for mediating cell cycle progression
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
US6066738A
(en)
|
1996-01-30 |
2000-05-23 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
AU704087B2
(en)
|
1996-01-30 |
1999-04-15 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5817457A
(en)
|
1996-02-07 |
1998-10-06 |
Ma Bioservices, Inc. |
Methods and kits for detecting viral reverse transcriptase activity in a sample using an acidic pH or an elevated temperature
|
AU2063197A
(en)
|
1996-03-04 |
1997-09-22 |
Massachusetts Institute Of Technology |
Materials and methods for enhancing cellular internalization
|
WO1997033899A1
(en)
|
1996-03-14 |
1997-09-18 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule i
|
CA2249195A1
(en)
|
1996-03-18 |
1997-09-25 |
Board Of Regents, The University Of Texas System |
Immunoglobin-like domains with increased half lives
|
EP0904278A4
(en)
|
1996-03-22 |
1999-09-15 |
Human Genome Sciences Inc |
MOLECULE II INDUCER OF APOPTOSIS
|
US6063930A
(en)
|
1996-04-03 |
2000-05-16 |
Merck & Co., Inc. |
Substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
|
US6080870A
(en)
|
1996-04-03 |
2000-06-27 |
Merck & Co., Inc. |
Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors
|
US5891889A
(en)
|
1996-04-03 |
1999-04-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5883105A
(en)
|
1996-04-03 |
1999-03-16 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5834597A
(en)
*
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
US6300501B1
(en)
|
1996-05-22 |
2001-10-09 |
Warner-Lambert Company |
Histidine-(N-benzyl glycinamide) inhibitors of protein farnesyl transferase
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US5883120A
(en)
|
1997-06-16 |
1999-03-16 |
Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University |
Antifungal activity of the spongistatins
|
US5648239A
(en)
|
1996-06-21 |
1997-07-15 |
Incyte Pharmaceuticals, Inc. |
Human camp-dependent protein kinase inhibitor homolog
|
CA2259222A1
(en)
|
1996-06-27 |
1997-12-31 |
Pfizer Inc. |
Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
|
CZ301044B6
(cs)
|
1996-08-12 |
2009-10-21 |
Mitsubishi Tanabe Pharma |
Léciva obsahující amidové deriváty inhibující Rho kinázu
|
US6030982A
(en)
|
1996-09-13 |
2000-02-29 |
Schering Corporationm |
Compounds useful for inhibition of farnesyl protein transferase
|
US5945429A
(en)
|
1996-09-13 |
1999-08-31 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6040305A
(en)
|
1996-09-13 |
2000-03-21 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US5885834A
(en)
|
1996-09-30 |
1999-03-23 |
Epstein; Paul M. |
Antisense oligodeoxynucleotide against phosphodiesterase
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
JP2001527527A
(ja)
*
|
1996-11-27 |
2001-12-25 |
デュポン ファーマシューティカルズ カンパニー |
新規インテグリン受容体拮抗薬
|
WO1998023289A1
(en)
|
1996-11-27 |
1998-06-04 |
The General Hospital Corporation |
MODULATION OF IgG BINDING TO FcRn
|
EP2314625B1
(en)
|
1996-12-03 |
2014-05-07 |
Amgen Fremont Inc. |
Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
|
US6093737A
(en)
|
1996-12-30 |
2000-07-25 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5939439A
(en)
|
1996-12-30 |
1999-08-17 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6013662A
(en)
|
1996-12-30 |
2000-01-11 |
Rhone-Poulenc Rorer S.A. |
Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments
|
ATE287257T1
(de)
|
1997-01-16 |
2005-02-15 |
Massachusetts Inst Technology |
Zubereitung von partikelhaltigen arzneimitteln zur inhalation
|
EP0975603A1
(en)
|
1997-01-29 |
2000-02-02 |
Zeneca Limited |
Inhibitors of farnesyl protein transferase
|
US6590079B2
(en)
|
1997-01-30 |
2003-07-08 |
Ixsys, Incorporated |
Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
|
ZA981080B
(en)
|
1997-02-11 |
1998-08-12 |
Warner Lambert Co |
Bicyclic inhibitors of protein farnesyl transferase
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
TW591030B
(en)
|
1997-03-10 |
2004-06-11 |
Janssen Pharmaceutica Nv |
Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
|
DE69808609T2
(de)
*
|
1997-04-11 |
2003-06-12 |
Searle & Co |
Antagonistische anti-avb3 integrin antikörper
|
US5968741A
(en)
|
1997-04-11 |
1999-10-19 |
Cedars-Sinai Medical Center |
Methods of diagnosing a medically resistant clinical subtype of ulcerative colitis
|
US7227002B1
(en)
|
1997-04-14 |
2007-06-05 |
Micromet Ag |
Human antibodies that bind human 17-A1/EpCAM tumor antigen
|
AU7467898A
(en)
*
|
1997-04-21 |
1998-11-13 |
Arch Development Corporation |
Fc receptor non-binding anti-cd3 monoclonal antibodies deliver a partial cr signal and induce clonal anergy
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
US6159984A
(en)
|
1997-06-17 |
2000-12-12 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
US6211193B1
(en)
|
1997-06-17 |
2001-04-03 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6225322B1
(en)
|
1997-06-17 |
2001-05-01 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6228865B1
(en)
|
1997-06-17 |
2001-05-08 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6239140B1
(en)
|
1997-06-17 |
2001-05-29 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6051582A
(en)
|
1997-06-17 |
2000-04-18 |
Schering Corporation |
Compounds useful for inhibition of farnesyl protein transferase
|
US6171787B1
(en)
|
1997-06-26 |
2001-01-09 |
Abbott Laboratories |
Member of the TNF family useful for treatment and diagnosis of disease
|
US6096707A
(en)
*
|
1997-07-11 |
2000-08-01 |
Biotie Therapies Ltd. |
Integrin binding peptide and use thereof
|
HUP0003194A3
(en)
|
1997-08-15 |
2003-03-28 |
Cephalon Inc West Chester |
Use of tyrosine kinase inhibitor in synergic pharmaceutical composition treating prostate cancer
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
US6103723A
(en)
|
1997-10-17 |
2000-08-15 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
WO1999020611A1
(en)
|
1997-10-22 |
1999-04-29 |
Zeneca Limited |
Imidazole derivatives and their use as farnesyl protein transferase inhibitors
|
JP2001520222A
(ja)
|
1997-10-22 |
2001-10-30 |
ゼネカ・リミテッド |
イミダゾール誘導体およびファルネシルタンパク質トランスフェラーゼインヒビターとしてのそれらの使用
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
KR20010031713A
(ko)
|
1997-11-03 |
2001-04-16 |
벤슨 로버트 에이치. |
맥관형성 및 종양 성장 억제제인 맥관 내피 세포 성장억제제
|
US6124465A
(en)
|
1997-11-25 |
2000-09-26 |
Rhone-Poulenc S.A. |
Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments
|
EP1049693A1
(en)
|
1997-11-26 |
2000-11-08 |
Du Pont Pharmaceuticals Company |
1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
|
BR9815423A
(pt)
|
1997-11-28 |
2000-10-17 |
Lg Chemical Ltd |
Composto derivado de imidazol, processo para preparar um derivado de imidazol, e, composição farmacêutica.
|
US6054466A
(en)
|
1997-12-04 |
2000-04-25 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6242196B1
(en)
|
1997-12-11 |
2001-06-05 |
Dana-Farber Cancer Institute |
Methods and pharmaceutical compositions for inhibiting tumor cell growth
|
US6048861A
(en)
*
|
1997-12-17 |
2000-04-11 |
Merck & Co., Inc. |
Integrin receptor antagonists
|
US6335156B1
(en)
|
1997-12-18 |
2002-01-01 |
The Johns Hopkins University School Of Medicine |
14-3-3σ arrests the cell cycle
|
ES2185307T3
(es)
|
1998-02-02 |
2003-04-16 |
Lg Chemical Ltd |
Inhibidores de la farnesil transferasa que tienen una estructura piperidinica y procedimiento para su preparacion.
|
PT1076663E
(pt)
|
1998-04-27 |
2004-06-30 |
Warner Lambert Co |
Derivados funcionalizados de alquilo e alcenilo de cadeia lateral de glicinamidas como inibidores de farnesil transferase
|
JP2002518432A
(ja)
|
1998-06-24 |
2002-06-25 |
アドバンスト インハレーション リサーチ,インコーポレイテッド |
吸入器から放出される大多孔性粒子
|
TR200003882T2
(tr)
|
1998-07-06 |
2001-06-21 |
Janssen Pharmaceutica N.V. |
Artropatilerin tedavisi için farnesil protein transferaz inhibitörleri.
|
US6034053A
(en)
|
1998-07-13 |
2000-03-07 |
Wayne Hughes Institute |
EGF-isoflavone conjugates for the prevention of restenosis
|
EP1105389A4
(en)
|
1998-08-13 |
2001-10-17 |
Merck & Co Inc |
INTEGRIN RECEPTOR ANTAGONISTS
|
US6160099A
(en)
*
|
1998-11-24 |
2000-12-12 |
Jonak; Zdenka Ludmila |
Anti-human αv β3 and αv β5 antibodies
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
US6372747B1
(en)
|
1998-12-18 |
2002-04-16 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
US6362188B1
(en)
|
1998-12-18 |
2002-03-26 |
Schering Corporation |
Farnesyl protein transferase inhibitors
|
FR2787327B1
(fr)
|
1998-12-21 |
2003-01-17 |
Aventis Pharma Sa |
Compositions contenant des inhibiteurs de farnesyle transferase
|
US6432959B1
(en)
|
1998-12-23 |
2002-08-13 |
Schering Corporation |
Inhibitors of farnesyl-protein transferase
|
ATE248170T1
(de)
|
1999-01-11 |
2003-09-15 |
Univ Princeton |
Kinase-inhibitoren mit hoher affinität zur ziel detektion und ihre verwendung
|
US6399633B1
(en)
|
1999-02-01 |
2002-06-04 |
Aventis Pharmaceuticals Inc. |
Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation
|
US6245759B1
(en)
|
1999-03-11 |
2001-06-12 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
US6143766A
(en)
|
1999-04-16 |
2000-11-07 |
Warner-Lambert Company |
Benzopyranone and quinolone inhibitors of ras farnesyl transferase
|
US6458935B1
(en)
|
1999-06-23 |
2002-10-01 |
Merck & Co., Inc. |
Radiolabeled farnesyl-protein transferase inhibitors
|
US6531580B1
(en)
|
1999-06-24 |
2003-03-11 |
Ixsys, Inc. |
Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
|
ATE440111T1
(de)
|
1999-11-29 |
2009-09-15 |
Bac Ip B V |
Immobilisierte antigenbindende moleküle aus einer domäne
|
US6403581B1
(en)
|
2000-01-19 |
2002-06-11 |
American Cyanamid Company |
Method of inhibition of farnesyl-protein transferase using substituted benz (cd) indol-2-imine and-amine derivatives
|
WO2002043660A2
(en)
|
2000-11-28 |
2002-06-06 |
Mediummune, Inc |
Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
|
AU2001259063A1
(en)
|
2000-04-12 |
2001-10-30 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
ATE457177T1
(de)
*
|
2000-05-03 |
2010-02-15 |
Medimmune Llc |
Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
|
US6818216B2
(en)
*
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
US6855493B2
(en)
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
AU2001297896A1
(en)
|
2000-12-08 |
2003-01-02 |
Medimmune, Inc. |
Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
|
DK1355919T3
(da)
*
|
2000-12-12 |
2011-03-14 |
Medimmune Llc |
Molekyler med længere halveringstider, sammensætninger og anvendelser deraf
|
CN101921732A
(zh)
*
|
2001-01-19 |
2010-12-22 |
维洛诺瓦蒂夫公司 |
在易感哺乳动物中引起呼吸道疾病的病毒
|
US20030044406A1
(en)
|
2001-03-02 |
2003-03-06 |
Christine Dingivan |
Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents
|
MXPA03007878A
(es)
|
2001-03-02 |
2004-07-08 |
Medimmune Inc |
Metodos de prevencion o tratamiento de alteraciones inflamatorias o autoinmunes mediante la administracion de los antagonistas alfav, beta3 de integrina.
|
US6630755B2
(en)
|
2001-11-16 |
2003-10-07 |
James T. Petriello |
Guardian personnel protection system
|
AU2003213682C1
(en)
|
2002-03-04 |
2008-06-12 |
Medimmune, Inc. |
Methods of preventing or treating disorders by administering an integrin alphavbeta3 antagonist in combination with an HMG-CoA reductase inhibitor or a bisphosphonate
|
JP2005533001A
(ja)
|
2002-03-04 |
2005-11-04 |
メディミューン,インコーポレーテッド |
インテグリンαvβ3アンタゴニストを他の物質と併用投与する癌の予防または治療方法
|
CA2481747A1
(en)
*
|
2002-04-12 |
2003-10-23 |
Medimmune, Inc. |
Recombinant anti-interleukin-9 antibodies
|
CA2485373A1
(en)
|
2002-05-10 |
2003-11-20 |
Medimmune, Inc. |
Epha2 monoclonal antibodies and methods of use thereof
|
US20040091486A1
(en)
*
|
2002-05-10 |
2004-05-13 |
Kinch Michael S. |
EphA2 agonistic monoclonal antibodies and methods of use thereof
|
US7425618B2
(en)
*
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
AU2004229527B2
(en)
|
2003-04-11 |
2009-08-20 |
Medimmune, Llc |
Methods of preventing or treating respiratory conditions
|
KR20120035234A
(ko)
*
|
2003-04-11 |
2012-04-13 |
메디뮨 엘엘씨 |
재조합 il?9 항체 및 그의 용도
|